Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve 1. Unaudited Standalone and Consolidated Results along with Limited Review Report for the Quarter and Nine Months ended 31st December, 2024;2. Any other business with the permission of Chairman.
Board Meeting Intimation for Intimation Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Story so far
Earlier from Vivanza Biosciences
- Vivanza Biosciences Ltd. Press Release Jan 15 2025
- Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Vivanza Biosciences Ltd. Press Release Dec 27 2024
- Closure of Trading Window
- Vivanza Biosciences Ltd. Press Release Dec 20 2024
Later from Vivanza Biosciences
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
- Vivanza Biosciences Ltd. Press Release Jan 30 2025
- Results For Quarter And Nine Months Ended 31St December, 2024
- Outcome Of The Board Meeting.
- Vivanza Biosciences Ltd. Press Release Jan 31 2025
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences